Journals / Gülhane Tıp Dergisi / 2022 / Cilt: 64 - Sayı: 2

Low serum zinc and total antioxidant capacity levels in individuals with premenstrual syndrome

Pages
189–196
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Serum TAC level, dietary antioxidant, and PUFA intake level were positively correlated (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aims: The aim of this study was to evaluate serum zinc (Zn) level, total antioxidant capacity (TAC) level, and nutritional status in premenstrual syndrome (PMS).
📊
Key Findings & Data:Methods: This cross-sectional, single-center study and case-control study enrolled university students 18 to 28 years old.
💡
Conclusion & Impact:Serum TAC level, dietary antioxidant, and PUFA intake level were positively correlated (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aims: The aim of this study was to evaluate serum zinc (Zn) level, total antioxidant capacity (TAC) level, and nutritional status in premenstrual syndrome (PMS). Methods: This cross-sectional, single-center study and case-control study enrolled university students 18 to 28 years old. Serum TAC analysis was performed via the enzyme-linked immunosorbent assay. Serum Zn level was measured using atomic absorption spectrometry. Nutritional status was assessed using the 24-hour dietary recall. Results: The study population consisted of 110 individuals (mean±Sstandart deviation age: 20.3±1.9 years), 48 subjects with PMS, and 62 subjects without PMS. Individuals with PMS had lower serum Zn levels (28.04±31.40 µmol/L vs. 11.67±6.42 µmol/L, respectively), TAC levels (1.60±0.42 mmol/L vs. 1.47±0.10 mmol/L), and higher body mass index (22.30±02.71 kg/m2 vs. 23.73±3.44 kg/m2 ) than individuals without PMS. Individuals with PMS had lower fiber, polyunsaturated fatty acid (PUFA), vitamins E, vitamin B1, vitamin B2, vitamin B6, vitamin C, folate, and magnesium, and higher carbohydrate and sodium intake than those without PMS but the differences did not reach statistical significance. Serum TAC level, dietary antioxidant, and PUFA intake level were positively correlated (p

🔖

Cite This Article

GÜÇLÜ, A., ZENGİN, H., MUŞLU, Ö., AKARSU, S., AĞAGÜNDÜZ, D., CÖMERT, T. K., ÖZTAŞ, B. (2022). Low serum zinc and total antioxidant capacity levels in individuals with premenstrual syndrome. Gülhane Tıp Dergisi, Cilt: 64 - Sayı: 2, 189–196. https://ajindex.com/articles/526748

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Freeman EW. Premenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosis. Psychoneuroendocrinology. 2003;28(Suppl 3):25-37
  2. Halbreich U. The diagnosis of premenstrual syndromes and premenstrual dysphoric disorder--clinical procedures and research perspectives. Gynecol Endocrinol. 2004;19:320-334
  3. Steiner M, Pearlstein T, Cohen LS, et al. Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs. J Womens Health (Larchmt). 2006;15:57-69
  4. Alpay FB, Turhan NO. Intermittent versus continuous sertraline therapy in the treatment of premenstrual dysphoric disorders. Int J Fertil Womens Med. 2001;46:228-231
  5. Jarvis CI, Lynch AM, Morin AK. Management Strategies for Premenstrual syndrome/premenstrual dysphoric disorder. Ann Pharmacother. 2008;42:967-978
  6. A DM, K S, A D, Sattar K. Epidemiology of Premenstrual Syndrome (PMS)-A Systematic Review and Meta-Analysis Study. J Clin Diagn Res. 2014;8:106-109. Erratum in: J Clin Diagn Res. 2015;9:ZZ05
  7. Kahyaoglu Sut H, Mestogullari E. Effect of Premanstrual Syndrome on Work-Related Quality of Life in Turkish Nurses. Saf Health Work. 2016;7:78-82
  8. Goker A, Artunc-Ulkumen B, Aktenk F, Ikiz N. Premenstrual syndrome in Turkish medical students and their quality of life. J Obstet Gynaecol. 2015;35:275-278
  9. Hantsoo L, Epperson CN. Allopregnanolone in premenstrual dysphoric disorder (PMDD): Evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle. Neurobiol Stress. 2020;12:100213
  10. Szmidt MK, Granda D, Sicinska E, et al. Primary Dysmenorrhea in Relation to Oxidative Stress and Antioxidant Status: A Systematic Review of Case-Control Studies. Antioxidants (Basel). 2020;15:9:994
  11. Granda D, Szmidt MK, Kaluza J. Is Premenstrual Syndrome Associated with Inflammation, Oxidative Stress and Antioxidant Status? A Systematic Review of Case-Control and CrossSectional Studies. Antioxidants (Basel). 2021;10:604
  12. Duvan CI, Cumaoglu A, Turhan NO, Karasu C, Kafali H. Oxidant/antioxidant status in premenstrual syndrome. Arch Gynecol Obstet. 2011;283:299-304
  13. Hofmeister S, Bodden S. Premenstrual Syndrome and Premenstrual Dysphoric Disorder. Am Fam Physician. 2016;94:236-240
  14. Khanzode SD, Dakhale GN, Khanzode SS, Saoji A, Palasodkar R. Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors. Redox Rep. 2003;8:365-370
  15. Arranz L,